AWM Investment Company Reports 4.2% Stake in CervoMed Inc. (CRVO) via Warrants

AWM Investment Company, Inc. filed a Schedule 13G/A on April 7, 2026, reporting a beneficial ownership of 405,165 shares of CervoMed Inc. (CRVO), representing 4.2% of the company's common stock. This filing reflects an increase from a previously reported 0.0% position. The shares are held through various investment vehicles for which AWM serves as the investment adviser, including Special Situations Fund III QP, L.P. (235,126 warrants), Special Situations Life Sciences Fund, L.P. (101,291 warrants), and Special Situations Cayman Fund, L.P. (68,748 warrants). David M. Greenhouse and Adam C. Stettner, as controlling principals of AWM and members of the respective general partners, share control over these securities. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. Because the ownership level is now below the 5% threshold, this amendment highlights AWM's current position as of the event date on March 31, 2026.